🔎 Trials Near Me

Domov › Rak jajčnikov › Kentucky

Klinične študije za Rak jajčnikov v Kentucky

25 študij za Rak jajčnikov išče udeležence na lokacijah v Kentucky.

Mesta v Kentucky

Uradno besedilo študije (angleško)

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

  • CommonSpirit Saint Joseph Medical Center - East Lexington, Lexington
  • University of Kentucky/Markey Cancer Center, Lexington
Vključevanje udeležencevFaza 2
Vse starosti · Vsi spoli · Posodobljeno 2. okt. 2026 · NCT05564377

A Study of Azenosertib (ZN-c3) in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer

  • Site 0251 - Norton Cancer Institute, Louisville
Vključevanje udeležencevFaza 2
Starost 18 in več · Ženske · Posodobljeno 29. sep. 2026 · NCT05128825

A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.

  • Baptist Health Lexington /ID# 275218, Lexington
  • Norton Cancer Institute - St. Matthews /ID# 276173, Louisville
Vključevanje udeležencevFaza 2
Starost 18 in več · Ženske · Posodobljeno 29. sep. 2026 · NCT06890338

A Study to Assess Adverse Events and Change in Disease Activity of Multiple Treatment Combinations With Intravenous Mirvetuximab Soravtansine in Adult Participants With Ovarian Cancer

  • Baptist Health Lexington /ID# 278267, Lexington
Vključevanje udeležencevFaza 2
Starost 18 in več · Ženske · Posodobljeno 22. sep. 2026 · NCT07059845

A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer

  • Baptist Health Lexington, Lexington
  • Norton Women's and Children's Hospital, Louisville
Vključevanje udeležencevFaza 3
Starost 18 in več · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT07213804

Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors

  • Norton Cancer Institute, Louisville
Vključevanje udeležencevFaza 1
Starost 18 in več · Vsi spoli · Posodobljeno 21. sep. 2026 · NCT05983432

A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression

  • Norton Cancer Institute, Louisville
Vključevanje udeležencevFaza 2
Starost 18–99 · Ženske · Posodobljeno 15. sep. 2026 · NCT07023627

Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression

  • St Elizabeth Healthcare, Edgewood
Vključevanje udeležencevFaza 3
Starost 18 in več · Ženske · Posodobljeno 15. sep. 2026 · NCT07214779

FiH Study to Investigate Safety, PK and Efficacy of the NaPi2b ADC TUB-040 in Patients With PROC or r/r Adenocarcinoma NSCLC

  • Norton Cancer Institute Research, Louisville
Vključevanje udeležencevFaza 1/2
Starost 18 in več · Vsi spoli · Posodobljeno 14. sep. 2026 · NCT06303505

Investigation of Ubamatamab Combination Therapy in Adult Participants With Platinum-Resistant Ovarian Cancer

  • Norton Cancer Institute, St. Matthews Clinic, Louisville
Vključevanje udeležencevFaza 2
Starost 18 in več · Ženske · Posodobljeno 14. sep. 2026 · NCT06787612

A Phase 1 Study of LNCB74 in Advanced Solid Tumors

  • St. Elizabeth Healthcare, Edgewood
Vključevanje udeležencevFaza 1
Starost 18 in več · Vsi spoli · Posodobljeno 21. avg. 2026 · NCT06774963

Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity

  • University of Kentucky/Markey Cancer Center, Lexington
Vključevanje udeležencevFaza 2/3
Starost 18 in več · Vsi spoli · Posodobljeno 19. avg. 2026 · NCT07001748

A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer

  • Baptist Health Corbin, Corbin
  • Baptist Health Lexington, Lexington
  • Norton Hospital Pavilion and Medical Campus, Louisville
  • in še 5
Vključevanje udeležencev
Starost 35–50 · Ženske · Posodobljeno 7. avg. 2026 · NCT04251052

Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer

  • CommonSpirit Saint Joseph Hospital - Bardstown, Bardstown
  • Baptist Health Corbin, Corbin
  • Commonwealth Cancer Center-Corbin, Corbin
  • in še 10
Vključevanje udeležencevFaza 3
Starost 18 in več · Vsi spoli · Posodobljeno 7. avg. 2026 · NCT06580314

A Study of Raludotatug Deruxtecan (R-DXd) in Subjects With Platinum-resistant, High-grade Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

  • St. Elizabeth Medical Center, Edgewood
Vključevanje udeležencevFaza 2/3
Starost 18 in več · Vsi spoli · Posodobljeno 28. jul. 2026 · NCT06161025

Lead-212 PSV359 Therapy for Patients With Solid Tumors

  • University of Kentucky, Lexington
Vključevanje udeležencevFaza 1/2
Starost 18–90 · Vsi spoli · Posodobljeno 6. jul. 2026 · NCT06710756

EXoPERT EMERALD Clinical Study

  • Lexington VA Healthcare System, Lexington
  • KCTL, Louisville
Vključevanje udeležencevOpazovalna študijaVabljeni zdravi prostovoljci
Starost 45 in več · Vsi spoli · Posodobljeno 1. jul. 2026 · NCT07186296

A Study to Assess Adverse Events and Change in Disease Activity in Participants With Platinum-Resistant Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha Expression Treated With Intravenously (IV) Infused Mirvetuximab Soravtansine

  • St. Elizabeth Medical Center - Edgewood /ID# 272113, Edgewood
  • Baptist Health Lexington /ID# 272211, Lexington
Vključevanje udeležencevFaza 2
Starost 18 in več · Ženske · Posodobljeno 26. maj 2026 · NCT06682988

Heated Intraperitoneal Chemotherapy Followed by Niraparib for Ovarian, Primary Peritoneal and Fallopian Tube Cancer

  • University of Kentucky Medical Center, Lexington
Vključevanje udeležencevFaza 3
Starost 18 in več · Ženske · Posodobljeno 16. apr. 2026 · NCT05659381

Flat Dose vs. Weight-based IP Chemotherapy for CRS/HIPEC

  • University of Kentucky, Lexington
Vključevanje udeležencevFaza 2
Starost 18 in več · Vsi spoli · Posodobljeno 1. apr. 2026 · NCT04779554

Combination Therapy for Recurrent Ovarian Cancer

  • UofL Health Brown Cancer Center, Louisville
Vključevanje udeležencevFaza 1/2
Starost 18 in več · Ženske · Posodobljeno 19. mar. 2026 · NCT05610735

A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation

  • University of Kentucky Markey Cancer Center, Lexington
Vključevanje udeležencevFaza 1
Starost 18 in več · Vsi spoli · Posodobljeno 13. feb. 2026 · NCT06778863

First in Human Study of TORL-1-23 in Participants With Advanced Cancer

  • University of Kentucky Medical Center, Lexington
Vključevanje udeležencevFaza 1
Starost 18 in več · Vsi spoli · Posodobljeno 13. feb. 2026 · NCT05103683

cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease

  • Baptist Corbin, Corbin
  • Baptist Hardin, Elizabethtown
  • Baptist Lexington, Lexington
Vključevanje udeležencevOpazovalna študijaVabljeni zdravi prostovoljci
Starost 40 in več · Vsi spoli · Posodobljeno 20. jan. 2026 · NCT05366881

Transvaginal Ultrasonography as a Screening Method for Ovarian Cancer

  • Markey Cancer Center, Lexington
Vključevanje udeležencevVabljeni zdravi prostovoljci
Starost 24 in več · Ženske · Posodobljeno 14. nov. 2025 · NCT04473833

Vir: ClinicalTrials.gov, podatki pridobljeni 5. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.